Concomitant thyroid disease in patients operated for primary hyperparathyroidism

Česká verzia

Authors: P. Libánský ¹; S. Adámek ¹; P. Broulík ²; M. Fialová ¹; J. Šedý ³; J. Tvrdoň ¹; M. Vaculová ¹; R. Lischke ¹
Authors place of work: III. chirurgická klinika 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Motol, Praha ¹; III. interní klinika 1. lékařské fakulty Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha ²; Klinika zubního lékařství, Lékařská fakulta Univerzity Palackého v Olomouci ³
Published in the journal: Rozhl. Chir., 2021, roč. 100, č. 1, s. 17-20.
Category: Original articles
doi: https://doi.org/10.33699/PIS.2021.100.1.17–20

Summary

Introduction: Parathyroid and thyroid diseases are ones of the most common endocrine diseases, but simultaneous surgical treatment of both endocrine systems is still under discussion.

Methods: We retrospectively evaluated 1,574 patients operated for primary hyperparathyroidism at the 3^rd Department of Surgery, 1^st Faculty Medicine, Charles University and University Hospital Motol in Prague with the thyroid and parathyroid ultrasound reports available. The patients were divided into two groups – with and without thyroid surgery.

Results: Thyroid surgery was performed in 34% of patients with primary hyperparathyroidism. Group 2, where thyroid surgery was performed, showed a higher proportion of reported abnormal thyroid sonographic findings (74%), a higher proportion of bilateral throat exploration (69%) and a longer hospital stay (3.3 days).

Conclusion: A patient indicated for surgery for parathyroid disease should also be indicated for possible thyroid surgery.

Keywords:

primary hyperparathyroidism – parathyroidectomy – thyroid disease

Zdroje

Golden S, Robinson K, Saldanha I, et al. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. The Journal of Clinical Endocrinology&Metabolism 2009;94:1853–1878. doi: 10.1210/jc.2008-2291.
Lundgren E, Rastad J, Thurfjell E, et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287–294. doi: 10.1007/s00268-002-6621-0.
Wermers R, Khosla S, Atkinson E, et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med. 1997;126:433–440. doi: 10.1359/JBMR.050910.
Panarese A, D’Andrea V, Pontone S, et al. Management of concomitant hyperparathyroidism and thyroid diseases in the elderly patients: a retrospective cohort study. Aging Clinical and Experimental Research 2017;29:29–33. doi: 10.1007/s40520-016-0665-8.
Heizmann O, Viehl C, Schmid R, et al. Impact of concomitant thyroid pathology on preoperative works for primary hyperparathyroidism. European Journal of Medical Research 2009;14:37–41. doi: 10.1186/2047-783X-14-1-37.
MoritaS, Somervell H, Umbricht C, et al. Evaluation for concomitant thyroidnodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 2008;144:862–867. doi: 10.1016/j.surg.2008.07.029.
Regal M, Paramo C, Cano R, et al. Coexistence of primary hyperparathyroidism and thyroid disease. Journal of Endocrinological Investigation 1999;22:191–197. doi: 10.1007/BF03343540.
Masatsugu T, Yamashita H, Noguchi S, et al. Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant thyroiddisease. Surgery Today 2005;35:351–356. doi: 10.1007/s00595-004-2952-9.
Latina A, Castellano E, Cesario F, et al. Unknown and already known thyroid abnormalities in primary hyperparathyroidism. Endocrine Practice 2018;24:628–633. doi: 10.1155/2020/2182539.
Ryan S, Courtney D, Timon C. Co-existent thyroid disease in patients treated for primary hyperparathyroidism: implications for clinical management. European Archives of Oto-Rhino-Laryngology 2015;272:419–423. doi: 10.1007/s00405-014-3000-z.
Bentrem D, Angelos P, Talamonti M, et al. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid 2002;12:1109–1112. doi: 10.1089/105072502321085207.
Castellano E, Benso P, Attanasio R, et al. Surgical approach to primary hyperparathyroidism in patients with concomitant thyroid diseases: A retrospective single center study. International Journal of Endocrinology 2020;10:21−27. doi: 10.1155/2020/2182539.
Halenka M, Fryšák Z, Koranda P, et al. Pseudocysta příštítného tělíska v terénu polynodózní strumy jako vzácná příčina primární hyperparatyreózy. Interní Med. 2006;12:551–553.
Broulík P. Hyperkalcemie: na co je třeba myslet a jaká vyšetření provést? Interní medicína pro praxi 2011;13:7−8.
Scerrino G, Melfa G, Raspanti C, et al. The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study. Langenbeck’s Archives of Surgery 2017;402:1095–1102. doi: 10.1007/s00423-017-1568-7.
Milas M, Mensah A, Alghoul M, et al. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid 2005;15:1055–1059. doi: 10.1089/thy.2005.15.1055.
Zini M, Attanasio R, Cesareo R, et al. AME position statement: primary hyperparathyroidism in clinical practice. Journal of Endocrinological Investigation 2012;35:2–21.
Wilhelm S, Wang T, Ruan D, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surgery 2016;151:959–968. doi:10.1001/jamasurg.2016.2310.
Halenka M, Fryšák Z, Koranda P, et al. Kombinace dosud asymptomatické primární hyperparatyreózy a papilokarcinomu štítné žlázy u pacienta s B-non-Hodgkinovým lymfomem. Interní Med. 2015;17:35–38.
Kosem M, Algun E, Kotan C, et al. Coexistent thyroidpathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chirurgica Belgica 2004;104:568–571. doi: 10.1080/00015458.2004.11679616.